About
Services
Industries
Press & insights
resources
contact
We're on a mission to help companies of all sizes identify the best locations, secure incentives, obtain development approvals and optimize energy strategies through Location Economics®.
BLS & Co. serves as location and incentives advisor to Roche, Swiss multinational healthcare leader, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012, supporting over $2.7 billion in announced investments.
BLS & Co. serves aslocation and incentives advisor to Roche, Swiss multinational healthcare company, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012 with four major projects announced as of 2026:
BLS & Co. utilizes an assortment of services – a process we call Location Economics® – to advise clients on location decisions. Discover our variety of offerings to help you navigate the complex decision making processes that occur when searching for a new location for your organization.
BLS & Co. specializes in a variety of industries and our dedicated team is compromised of experts in nearly all major categories.
At BLS & Co., we have executed wide variety of projects for our clients, which includes facilities such as headquarters, warehouses, and data centers.
Stay up to date with BLS & Co. by exploring our latest news and musings on the world of site selection and more.
We're proud to provide a few key resources to help get you started on your site selection journey.
Search our North American database for the right location for your company's HQ, R&D Facilities, and more.
Browse our regional resource guide for site selection in the U.S.
If your organization is confronting complex and sensitive location decisions, please reach out to schedule a confidential conversation.
Interested in a career opportunity with BLS & Co.? Click below to learn more about our growing team and view all current openings.
in investments
projects announced
announced new jobs
Life sciences location decisions have never been more complex. Companies across biotechnology, pharmaceuticals, diagnostics, medical devices and testing industries must balance access to scientific, engineering, commercial and manufacturing talent with growing demands for power, water, infrastructure and specialized facilities.
BLS & Co. helps companies navigate these tradeoffs to identify and qualify locations that can support increasingly complex operations, accelerate speed to market and manage risk and control costs. Drawing on decades of experience advising some of the world's leading life sciences companies, BLS brings together location strategy, labor market analysis, infrastructure and utility due diligence, incentives strategy and site development risk assessment to help clients make confident, long-term investment decisions.
BLS & Co. helps clients select locations for administrative, research, development and manufacturing facilities, as well as corporate headquarters, and works with companies to obtain economic development incentives. Our services include:
We are best known for the breadth and sophistication of our incentives advisory services and have been involved in transactions in almost every state. Through our international partners we are also able to serve clients elsewhere in North and South America as well as Europe and Asia.
BLS & Co. has advised global pharmaceutical leader Eli Lilly & Company (Lilly) on competitive site searches supporting 13 new global sites since 2020 accounting for more than $57 billion in announced investments in next-generation production facilities. Our engagements with Lilly date back more than two decades.
Since 2020, BLS has advised Lilly on the site selection and incentives negotiation for 10 new U.S. manufacturing and R&D sites, resulting in more than $50 billion in announced investment, 6,500 new positions and more than $2.9 billion in state and local incentives secured.
In Europe, BLS and our European partner firm, Location Decisions, have assisted Lilly with three recent manufacturing site selection requirements, resulting in more than $7.5 billion in investment and 2,000 announced jobs.
Across our relationship with Lilly, BLS has provided a full range of strategic location advisory services, including multi-state site selection, infrastructure due diligence, labor market analysis, incentives strategy & transaction management, utility & infrastructure evaluations, regulatory risk assessments, and incentives compliance support.
US Project Highlights
Europe Project Highlights
BLS & Co. has served as site selection and incentives advisor to Bristol Myers Squibb dating for more than two decades. Our engagements have included complex and highly competitive nationwide searches for both manufacturing and office projects resulting in over $3.3 billion in announced investment.
BLS & Co. served as site selection and incentives consultant for Bristol Myers Squibb’s new $2.3B multi-modal manufacturing facility in Houston, Texas. The project continued BLS & Co.'s decades-long relationship with BMS that has also involved substantial office and manufacturing projects in Florida and Massachusetts.
BLS & Co. serves as location and incentives advisor to Roche, Swiss multinational healthcare leader, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012, supporting over $2.7 billion in announced investments.
BLS & Co. serves aslocation and incentives advisor to Roche, Swiss multinational healthcare company, and its subsidiary Genentech, the South San Francisco-based biotechnology industry leader. Our engagements with Roche date back to 2012 with four major projects announced as of 2026:
Life sciences location decisions require companies to navigate complex considerations ranging from workforce and infrastructure to utilities, development timelines, incentives and regulatory requirements. BLS & Co. brings deep site selection and incentives experience to help life sciences companies evaluate these factors, mitigate risk and make informed location decisions.
This overview highlights BLS & Co.’s integrated capabilities across location strategy and site selection, incentives advisory, utility and energy strategy, labor market analysis, site readiness and implementation support. It also showcases the firm’s extensive life sciences experience, including work with Eli Lilly, Bristol Myers Squibb, AbbVie, Johnson & Johnson and Genentech on major manufacturing investments across the U.S. and Europe.
